From: Immune biomarkers in thymic epithelial tumors: expression patterns, prognostic value and comparison of diagnostic tests for PD-L1
N = 103 patients
Sex
Male
62 (60%)
Female
41 (40%)
Paraneoplasic syndrome
No
32 (76%)
Yes
10 (24%)
Missing
61
Recurrence
14 (22%)
50 (78%)
39
Survival
Alive
72 (81%)
Dead
17 (19%)
14 (non primary tumors)